tirzepatide weight loss testimonials Before and After: New Treatment Success Stories of Tirzepatide &

The platform helps match your goals to an effective GLP-1 after an initial intake survey and a clinician evaluation

Zepbound May Be Better If: Maximum weight loss is your primary goal SURMOUNT-5 clearly favours it You want more dose flexibility (six strengths to fine-tune tolerance) You also have moderate-to-severe obstructive sleep apnoea with obesity You prefer the cheaper self-drawn vial option via LillyDirect Wegovy May Be Better If: You have established cardiovascular disease Wegovy has an FDA-approved indication to reduce heart attack and stroke risk You dislike injections the oral tablet is now available Your insurance covers Wegovy but not Zepbound (it has been on the market longer and is on more formularies) You respond well to GLP-1-only therapy and tolerate it comfortably What Both Require: Neither drug works in isolation

Research Use Only

Both drugs come out of Eli Lilly, and both are dual agonists of the GLP-1 and GIP receptors

Fr die pharmazeutische Klrung ist die Angabe Ihrer Telefonnummer notwendig

Authors recommendations Elderly people: There are very limited data from people aged 85 years and over, so I would avoid